The improvement of walking capacity is a key objective of the rehabilitation of children with PC. There are different approaches from physiotherapy to address this need, including walking on the ground and on treadmill with partial weight support. Currently, there are robotic technologies adapted to the functional rehabilitation of patients. Assisted gait training with robotic devices such as the Walkbot allows a longer duration of training, at more variable speeds, and with a constant gait pattern adapted to the patient. This training, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. There are some studies that evaluate walking interventions on treadmill with partial weight support, on the ground and in assisted walking robot in patients with PC. Currently, there are no studies conducted that report the effectiveness of interventions performed with robotic walking training device Walkbot K on PC. However, studies in adults with Walkbot S, affected with neurological injury, have reported good results. Assisted gait training with robotic devices such as the Walkbot, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. However, due to the little evidence that exists, it is necessary to know the effectiveness of the Walkbot assisted walking robot in these patients by means of a clinical trial that allows to firmly establish the scope of its benefits.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
23
The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.
The control group will receive their usual Physical therapy sessions during 6 weeks.
Raquel Olmos Gómez
Yecla, Murcia, Spain
Ability and quality of walking.
Changes in Gross Motor Function Measure-88 (dimensions IV y V)
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Functionality and autonomy
Differences in the basic activities of daily life, measured with the PedsQL- Cerebral Palsy Module
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Muscle strength
Differences in muscle strength of lower limbs, measured with dynamometer.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Range of motion
Analyze if the range of joint mobility is increased in those joints that are more limited, measured with goniometer.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Spasticity
Changes in spasticity values, measured with the modified Ashworth Scale. Higher scores mean worse outcome. Minimum value is 0. Maximum value is 4.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Quality of walking: Edinburgh Visual Gait Scale
Changes in Edinburgh Visual Gait Scale values. Higher scores mean worse outcome. Minimum value is 0. Maximum value is 34.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Gait endurance
Changes in 6 minutes walk test
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.